1 completed, 1 withdrawn. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow C.Difficile Colitis: new trials by email Literature Review of C.Difficile Colitis trials Research Report on C.Difficile Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection Vancomycin, Placebo - Recurrent Clostridium Difficile Infection, Clostridium Difficile Infection | Phase 2 | Completed | University of Wisconsin, Madison | 79 | 2018-05-21 | 2025-05-25 |
| EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant fecal microbiota transplant - C.Difficile Colitis | Not applicable | Withdrawn | Milton S. Hershey Medical Center | 2016-09-15 | 2017-11-27 |
Enterocolitis, Pseudomembranous (2) · Clostridium Infections (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Digestive System Diseases (2) · Enterocolitis (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Intestinal Diseases (2) · Clostridium Infections (1)
Fecal Microbiota Transplantation (1) · Vancomycin (1)
Milton S. Hershey Medical Center (1) · University of Wisconsin, Madison (1)
United States (2)